The Role of the Immune Response in the Development of Medication-Related Osteonecrosis of the Jaw

Weidong Zhang,Ling Gao,Wenhao Ren,Shaoming Li,Jingjing Zheng,Shasha Li,Chunmiao Jiang,Shuying Yang,Keqian Zhi

DOI: https://doi.org/10.3389/fimmu.2021.606043

IF: 7.3

2021-01-01

Frontiers in Immunology

Abstract:Medication-related osteonecrosis of the jaw (MRONJ) is a rare but serious adverse drug effect. There are multiple hypotheses to explain the development of MRONJ. Reduced bone remodeling and infection or inflammation are considered central to the pathogenesis of MRONJ. In recent years, increasing evidence has shown that bisphosphonates (BPs)-mediated immunity dysfunction is associated with the pathophysiology of MRONJ. In a healthy state, mucosal immunity provides the first line of protection against pathogens and oral mucosal immune cells defense against potentially invading pathogens by mediating the generation of protective immunoinflammatory responses. In addition, the immune system takes part in the process of bone remodeling and tissue repair. However, the treatment of BPs disturbs the mucosal and osteo immune homeostasis and thus impairs the body's ability to resist infection and repair from injury, thereby adding to the development of MRONJ. Here, we present the current knowledge about immunity dysfunction to shed light on the role of local immune disorder in the development of MRONJ.